共 494 条
[1]
Miner P(2003)Gastric acid control with esomeprazole, lansoprazole, omeprazole, pantoprazole, and rabeprazole: a five-way crossover study Am J Gastroenterol 98 2616-2620
[2]
Katz PO(2003)Acid inhibition on the first day of dosing: comparison of four proton pump inhibitors Aliment Pharmacol Ther 17 1507-1514
[3]
Chen Y(2004)Esomeprazole 40 mg provides more effective intragastric acid control than lansoprazole 30 mg, omeprazole 20 mg, pantoprazole 40 mg and rabeprazole 20 mg in patients with gastro-oesophageal reflux symptoms Eur J Clin Pharmacol 60 531-539
[4]
Sostek M(2003)Meta-analysis: comparing the efficacy of proton pump inhibitors in short-term use Aliment Pharmacol Ther 17 1237-1245
[5]
Pantoflickova D(2004)The choice of proton pump inhibitor: does it matter? Basic Clin Pharmacol Toxicol 94 106-111
[6]
Dorta G(2006)Review article: intragastric and oesophageal pH monitoring in patients with gastro-oesophageal reflux disease Aliment Pharmacol Ther 23 3-11
[7]
Ravic M(1992)Role of gastric acid suppression in the treatment of gastro-oesophageal reflux disease Gut 33 118-124
[8]
Jornod P(1990)Is there an optimal degree of acid suppression for healing of duodenal ulcers? A model of the relationship between ulcer healing and acid suppression Gastroenterology 99 345-351
[9]
Blum AL(1990)The relationship between suppression of acidity and gastric ulcer healing rates Aliment Pharmacol Ther 4 25-33
[10]
Rohss K(2006)Clinical impact of CYP2C19 polymorphism on the action of proton pump inhibitors: a review of a special problem Int J Clin Pharmacol Ther 44 297-302